Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
100 participants
INTERVENTIONAL
2016-11-01
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Salbutamol in the Management of Transient Tachypnea of the New Born
NCT06921291
Inhaled Furosemide for Transient Tachypnea of Newborn
NCT04397991
Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)
NCT05006235
Community Based Management of Fast Breathing in Infants Aged < 60 Days in Low-income Settlements of Karachi
NCT01533818
Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn
NCT01858129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
with salbutamol
Furosemide Injection
efficacy of salbutamol and furosemide in TTN
with furosemide
Furosemide Injection
efficacy of salbutamol and furosemide in TTN
both furosemide and salbutamol
Furosemide Injection
efficacy of salbutamol and furosemide in TTN
no inervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Furosemide Injection
efficacy of salbutamol and furosemide in TTN
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Hour
7 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Armed Forces Hospital, Pakistan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
arshad khushdil
CONCULTANT PEDIATRICIAN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pediatrics
Rawalpindi, Punjab Province, Pakistan
Military Hospital
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TTN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.